What type of study is this?

This is a Cohort Study study (also classified as: Literature Review).

What question did this study set out to answer?

The study aims to understand the impact of financial hardship on treatment initiation delays in patients with hematologic malignancies.

December 8, 2025Blood

Adverse financial events and delayed treatment initiation among patients with hematologic malignancies

View Full Paper

Ask AI

Bookmark

The study aims to understand the impact of financial hardship on treatment initiation delays in patients with hematologic malignancies.
Retrospective analysis of patients with chronic myeloid leukemia, diffuse large B-cell lymphoma, and multiple myeloma from the FHCC Data Repository.
Identified patients diagnosed between 2012 and 2021 who received chemotherapy or targeted therapy within 1 year.
Calculated time to treatment initiation (TTI) and identified adverse financial events from credit reports.
24% of patients experienced adverse financial events at diagnosis.
Patients with adverse financial events had a significantly delayed TTI (48 vs. 41 days).
Financial hardship at diagnosis was linked to a higher likelihood of prolonged treatment start (TTI greater than 60 days).

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Retrospective analysis shows financial hardship at diagnosis delays treatment initiation in patients with hematologic malignancies, suggesting socioeconomic disparities impact care access.

Cite This Study

Andrew J. Cowan (2025) studied this question.

synapsesocial.com/papers/69362f484fa91c937236d6eb https://doi.org/10.1182/blood-2025-286

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis shows financial hardship at diagnosis delays treatment initiation in patients with hematologic malignancies, suggesting socioeconomic disparities impact care access.

Adverse financial events and delayed treatment initiation among patients with hematologic malignancies

Key Points

Discussion

Implication

Cite This Study

Adverse financial events and delayed treatment initiation among patients with hematologic malignancies

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider